US Stock MarketDetailed Quotes

TRVI Trevi Therapeutics

Watchlist

4.245
-0.015-0.35%

Trading Mar 4 10:58 ET

379.36MMarket Cap-9.65P/E (TTM)

Trevi Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Trevi Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
Nov 6, 2024	2024/Q3	0.000 / 0.000	--
Aug 8, 2024	2024/Q2	0.000 / 0.000	--
May 7, 2024	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

Nov 6, 20242024/Q30.000 / 0.000--

Aug 8, 20242024/Q20.000 / 0.000--

May 7, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Trevi Therapeutics Earnings Reports

Trevi Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6, 2024 16:26 ET

Trevi Therapeutics | 8-K: Trevi Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

Nov 6, 2024 16:17 ET

Trevi Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8, 2024 16:48 ET

Trevi Therapeutics | 8-K: Trevi Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates Reaffirming Clinical Trial Guidance

Aug 8, 2024 16:17 ET